510(k) K875161
K875161 is an FDA 510(k) premarket notification submitted by Wampole Laboratories for the device "MAT (TM) MICROALBUMIN TEST". The FDA issued a decision of Substantially Equivalent on February 17, 1988. The device falls under product code DCF (Albumin, Antigen, Antiserum, Control), a Class II device regulated under 21 CFR 866.5040. Wampole Laboratories has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- February 17, 1988
- Date Received
- December 15, 1987
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Albumin, Antigen, Antiserum, Control
- Device Class
- Class II
- Regulation Number
- 866.5040
- Review Panel
- IM
- Submission Type